Key result
Total creatine kinase slope assays had the same diagnostic power as optimized decision threshold assays for early myocardial infarction diagnosis, while creatine kinase-2 slope assays were inferior.
Why the study?
Do timed serial (slope) creatine kinase measurements improve the early diagnosis of myocardial infarction compared to conventional optimized decision threshold assays?
Observational
Do timed serial (slope) creatine kinase measurements improve the early diagnosis of myocardial infarction compared to conventional optimized decision threshold assays?
Optimized decision threshold assays for creatine kinase remain superior or equal to slope assays for the early diagnosis of myocardial infarction, and should be used in situations of diagnostic doubt.
Answers are grounded in this paper and cite their sources.
Slope assays confer no gain over thresholds for early MI diagnosis; leaves open the incremental value of serial CK testing.
We compared the diagnostic utility of recently proposed slope assays for serum creatine kinase and creatine kinase-2 with the optimized decision threshold assays. The former approach has been claimed to be superior to any other single diagnostic technique. We show, by ROC curve and likelihood ratio analyses, that the total creatine kinase slope assay possesses the same diagnostic power, when confidence intervals are used, as the optimized decision threshold assay. Moreover, slope assays of creatine kinase-2 were diagnostically inferior to the optimized decision threshold assays. Indeed, these latter, optimized, assays have the highest likelihood ratios for a positive test result of the available assays, and they should always be used in situations of diagnostic doubt.
No takes yet. Share an insight, caveat, or question.
Leung et al. (1991) conducted an observational in Myocardial Infarction. Timed serial (slope) creatine kinase assays vs. Optimized decision threshold assays was evaluated on Diagnostic utility (ROC curve and likelihood ratio). Total creatine kinase slope assays had the same diagnostic power as optimized decision threshold assays for early myocardial infarction diagnosis, while creatine kinase-2 slope assays were inferior.
Synapse has enriched 10 related papers. Consider them for comparative context: